Higher PSA level at diagnosis (1.16, 95% CI 1.05–1.27) was associated with an increased risk of upstaging in Gleason 3 + 4 FIR PCa patients (Table 4). The gene discussed is KLK3; the disease is posterior cortical atrophy.